DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1568)

Category

1568 Biopharma Reports

    In every disease market, a detailed understanding of unmet need is required to...
    In every disease market, a detailed understanding of unmet need is required to properly assess drug development opportunities and the vulnerability of marketed brands to new products.   The Unmet Need 2016 Dashboard consolidates the key components featured within each of your purchased...
    Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by...
    Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive muscle weakness due to the loss of anterior motor neurons. Nearly all cases of SMA are caused by homozygous deletion or mutation of the SMN1 gene. SMA ranges widely in severity, and symptom onset usually...
    Parkinson’s disease (PD) treatment is complex; the disease is heterogeneous,...
    Parkinson’s disease (PD) treatment is complex; the disease is heterogeneous, requiring individualized treatment and frequent adjustments (e.g., in dosing, in regimens) to achieve symptom control throughout a patient’s disease course. Since 2015, a handful of new therapies that address PD...
    Prostate cancer requires a multidisciplinary treatment approach that...
    Prostate cancer requires a multidisciplinary treatment approach that incorporates surgery, radiotherapy, hormonal therapy, chemotherapy, bone-metastases-targeted therapy, and, in the United States, immunotherapy. Both urologists and oncologists are involved in the management and treatment of...
    Despite advances in treatment, rates of mortality and hospitalization for...
    Despite advances in treatment, rates of mortality and hospitalization for worsening heart failure remain high among CHF patients, and development of therapies with improved efficacy is one of the greatest unmet needs. Furthermore, given that none of the currently available CHF treatments has proven...
    In an era when healthcare payers are demanding more value for the money they...
    In an era when healthcare payers are demanding more value for the money they spend on health services and pharmaceuticals, managed care organizations increasingly have focused on meeting nationally accepted quality measures that are used to judge their performance and, in turn, that MCOs use to hold...
    Despite the recent launches of several new therapies, adding to the range of...
    Despite the recent launches of several new therapies, adding to the range of pharmacotherapies available for treating PAH and contributing to the complexity of the PAH treatment algorithm, a number of key unmet needs remain. These include novel efficacious therapies for PAH able to prolong survival...
    Malignant melanoma requires a multidisciplinary treatment approach that...
    Malignant melanoma requires a multidisciplinary treatment approach that incorporates surgery, radiotherapy, immunotherapy, and small molecule-targeted therapies. Treatment decisions are influenced by disease stage, resectability, and in the unresectable or metastatic setting, BRAF-mutation status....
    In the United States, more than 32 million people suffer from unipolar...
    In the United States, more than 32 million people suffer from unipolar depression, an indication that consists of major depressive disorder, minor depression, and dysthymia. Unipolar depression is associated with a high rate of drug treatment, which encompasses an extensive range of antidepressant...
    The treatment landscape for advanced/metastatic renal cell carcinoma includes...
    The treatment landscape for advanced/metastatic renal cell carcinoma includes well-established angiogenesis and mTOR inhibitors, many of which have broad labels allowing their use across several treatment settings. The approval of the first PD-1 inhibitor in this indication, Opdivo, has begun to...
    The Human Immunodeficiency Virus (HIV) market is seeing growth due to the uptake...
    The Human Immunodeficiency Virus (HIV) market is seeing growth due to the uptake of new premium-priced antiretroviral agents, particularly the latest single-tablet regimens (STRs) with improved side-effect profiles that place an emphasis on safety and tolerability. Our Current Treatment content...
    Chronic kidney disease (CKD) is a general term for a set of heterogeneous...
    Chronic kidney disease (CKD) is a general term for a set of heterogeneous disorders that negatively affect the function and structure of the kidney. Because of the role of the kidney in many of the body’s regulatory functions, CKD is accompanied by a wide range of comorbidities and...
    Hepatitis C virus (HCV) chronic infections are a leading cause of advanced liver...
    Hepatitis C virus (HCV) chronic infections are a leading cause of advanced liver disease and hepatocellular carcinoma and a common indication for liver transplantation. The 2013-2015 FDA approvals of Gilead’s Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir) combined with Bristol...
    GMAS delivers global market access data, analytics, insights, and visualizations...
    GMAS delivers global market access data, analytics, insights, and visualizations through a single integrated and interactive platform. Combining data, insight, and analyst access, GMAS helps clients make the most informed decisions regarding countries to enter, strategies to deploy, and resources to...
    Cosentyx (US) is a three-wave syndicated report series that specifically...
    Cosentyx (US) is a three-wave syndicated report series that specifically tracks the introduction of Novartis’s Cosentyx (secukinumab), a potent, subcutaneous IL-17 inhibitor approved for the treatment of psoriasis (PsO). This report series is based on primary research data collected at...
    CHF patients are subject to high rates of mortality and morbidity; further,...
    CHF patients are subject to high rates of mortality and morbidity; further, frequent readmissions to the hospital mean that CHF is a significant healthcare burden. The Current Treatment Chronic Heart Failure (US) report offers a snapshot of how U.S. cardiologists prescribe currently available...
    1 - 20 of 1568